Loading
No insider purchase over the last 90 days. The latest was filed 28 Jul 2020.
Grindeks is a listed company. Filings by its managers are published through Nasdaq Baltic. The past year has been quiet: not a single insider filing for Grindeks. The previous disclosure was published on 28 July 2020.
This summary is built from Nasdaq Baltic disclosures alone and does not predict where the share price will go.
Grindeks is a Latvian pharmaceutical company specializing in the production of generic drugs and active pharmaceutical ingredients. It is listed on the Riga Stock Exchange under the symbol XRIS.